"Muscular Atrophy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Derangement in size and number of muscle fibers occurring with aging, reduction in blood supply, or following immobilization, prolonged weightlessness, malnutrition, and particularly in denervation.
| Descriptor ID |
D009133
|
| MeSH Number(s) |
C10.597.613.612 C23.300.070.500 C23.888.592.608.612
|
| Concept/Terms |
Muscular Atrophy- Muscular Atrophy
- Atrophies, Muscular
- Atrophy, Muscular
- Muscular Atrophies
- Atrophy, Muscle
- Atrophies, Muscle
- Muscle Atrophies
- Muscle Atrophy
Neurogenic Muscular Atrophy- Neurogenic Muscular Atrophy
- Atrophies, Neurogenic Muscular
- Atrophy, Neurogenic Muscular
- Muscular Atrophies, Neurogenic
- Muscular Atrophy, Neurogenic
- Neurogenic Muscular Atrophies
- Neurotrophic Muscular Atrophy
- Atrophies, Neurotrophic Muscular
- Atrophy, Neurotrophic Muscular
- Muscular Atrophies, Neurotrophic
- Muscular Atrophy, Neurotrophic
- Neurotrophic Muscular Atrophies
|
Below are MeSH descriptors whose meaning is more general than "Muscular Atrophy".
Below are MeSH descriptors whose meaning is more specific than "Muscular Atrophy".
This graph shows the total number of publications written about "Muscular Atrophy" by people in this website by year, and whether "Muscular Atrophy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 1 | 1 | 2 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 0 | 1 | 1 |
| 2021 | 2 | 0 | 2 |
| 2022 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Muscular Atrophy" by people in Profiles.
-
Targeted ablation of Fn14 receptor improves exercise capacity and inhibits neurogenic muscle atrophy. FASEB J. 2022 12; 36(12):e22666.
-
Supraphysiological activation of TAK1 promotes skeletal muscle growth and mitigates neurogenic atrophy. Nat Commun. 2022 04 22; 13(1):2201.
-
H19X-encoded miR-322(424)/miR-503 regulates muscle mass by targeting translation initiation factors. J Cachexia Sarcopenia Muscle. 2021 12; 12(6):2174-2186.
-
MyD88-mediated signaling intercedes in neurogenic muscle atrophy through multiple mechanisms. FASEB J. 2021 08; 35(8):e21821.
-
Therapeutic Targeting of PTEN in Duchenne Muscular Dystrophy. Mol Ther. 2021 01 06; 29(1):8-9.
-
CRISPR-Cas9-induced IGF1 gene activation as a tool for enhancing muscle differentiation via multiple isoform expression. FASEB J. 2020 01; 34(1):555-570.
-
Mouse myofibers lacking the SMYD1 methyltransferase are susceptible to atrophy, internalization of nuclei and myofibrillar disarray. Dis Model Mech. 2016 Mar; 9(3):347-59.
-
The role of myostatin and activin receptor IIB in the regulation of unloading-induced myofiber type-specific skeletal muscle atrophy. J Appl Physiol (1985). 2015 Sep 15; 119(6):633-42.
-
Neuromuscular responses to mechanical foot stimulation: the influence of loading and postural context. Aviat Space Environ Med. 2008 Sep; 79(9):844-51.
-
Plantar stimulation as a possible countermeasure to microgravity-induced neuromotor degradation. Aviat Space Environ Med. 2008 Aug; 79(8):787-94.